Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

An unnamed Novartis executive sold 925,400 Swiss francs (£778,665) worth of shares in the firm just weeks before the FDA made the public aware that...
Top 10 stories on Pharmafile.com this week!
The British Government is calling on logistics companies to bid for a £25 million contract to run express freight containers carrying daily...
Janssen’s has secured a label expansion from the European Commission for its Bruton's tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib),...
The Scottish Medicines Consortium (SMC) has announced its acceptance of Buvidal (buprenorphine prolonged-release solution for subcutaneous...
Cambridge, Massachusetts-based Brammer Bio is planning to set up a new manufacturing facility in Norton, Massachusetts.
The FDA-approved anti-parasitic drug nitazoxanide could be used as a treatment for Ebola, according to researchers from the Boston Children's...
European health experts have warned that a no-deal Brexit could worsen medicines shortages in the European Union.
Five senators, including presidential candidates Bernie Sanders and Elizabeth Warren, have condemned Novartis for using “falsified data… to obtain...
A US court has sided with Amgen in a legal battle over the patent on blockbuster rheumatoid arthritis drug Enbrel.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches